Skip to main content

BioLineRx Ltd.

BLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001498403

No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in BioLineRx Ltd. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
18
−9 vs. Q3 2022
Shares held
5.71M
−5.42M (−48.7%) vs. Q3 2022
Total value
$3.37M
−$6.93M (−67.3%) vs. Q3 2022
New holders
2
3 more added
Sold out
11
8 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 18 institutions
Q1 2021: 29 institutionsQ2 2021: 30 institutionsQ3 2021: 30 institutionsQ4 2021: 30 institutionsQ1 2022: 26 institutionsQ2 2022: 28 institutionsQ3 2022: 28 institutionsQ4 2022: 18 institutionsQ1 2023: 20 institutionsQ2 2023: 26 institutionsQ3 2023: 29 institutionsQ4 2023: 29 institutionsQ1 2024: 28 institutionsQ2 2024: 31 institutionsQ3 2024: 32 institutionsQ4 2024: 32 institutionsQ1 2025: 12 institutionsQ2 2025: 17 institutionsQ3 2025: 14 institutionsQ4 2025: 14 institutionsQ1 2026: 13 institutionsQ2 2026: 14 institutions
Value heldQ4 2022: $3.37M
Q1 2021: $13.5MQ2 2021: $4.01MQ3 2021: $6.69MQ4 2021: $5.09MQ1 2022: $1.99MQ2 2022: $1.36MQ3 2022: $10.3MQ4 2022: $3.37MQ1 2023: $2.91MQ2 2023: $1.97MQ3 2023: $2.46MQ4 2023: $1.75MQ1 2024: $1.47MQ2 2024: $2.42MQ3 2024: $1.34MQ4 2024: $435.9KQ1 2025: $28.0KQ2 2025: $302.1KQ3 2025: $104.3KQ4 2025: $135.6KQ1 2026: $45.2KQ2 2026: $206.7K
Institutions holding BLRX and their total value by quarter
QuarterHoldersValue
Q2 202614$206.7K
Q1 202613$45.2K
Q4 202514$135.6K
Q3 202514$104.3K
Q2 202517$302.1K
Q1 202512$28.0K
Q4 202432$435.9K
Q3 202432$1.34M
Q2 202431$2.42M
Q1 202428$1.47M
Q4 202329$1.75M
Q3 202329$2.46M
Q2 202326$1.97M
Q1 202320$2.91M
Q4 202218$3.37M
Q3 202228$10.3M
Q2 202228$1.36M
Q1 202226$1.99M
Q4 202130$5.09M
Q3 202130$6.69M
Q2 202130$4.01M
Q1 202129$13.5M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding BioLineRx Ltd.; share changes are against Q3 2022.

Institutions holding BLRX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Altium Capital Management LP3,103,635$1.83M0.94%−1,045,627−25.2%Reduced
Sabby Management, LLC1,751,992$1.03M2.77%−1,282,115−42.3%Reduced
Renaissance Technologies LLC257,900$152.0K0.00%+189,678+278.0%Added
Morgan Stanley252,952$149.2K0.00%−9,607−3.7%Reduced
LPL Financial LLC117,710$69.4K0.00%+71,134+152.7%Added
Atria Wealth Solutions, Inc.113,366$66.9K0.00%+9,334+9.0%Added
Geode Capital Management, LLC32,026$18.0K0.00%00.0%Unchanged
Geneos Wealth Management Inc.23,500$13.9K0.00%00.0%Unchanged
Cutter & CO Brokerage, Inc.16,667$9.83K0.00%−2,000−10.7%Reduced
Belpointe Asset Management LLC16,000$9.44K0.00%+16,000New
Creative Planning14,582$8.60K0.00%00.0%Unchanged
UBS Group AG3,826$2.26K0.00%−8,967−70.1%Reduced
Group One Trading, L.P.3,088$1.82K0.00%−6,535−67.9%Reduced
Advisor Group Holdings, Inc.1,206$1.00K0.00%−9,451−88.7%Reduced
Royal Bank of Canada2,053$1.00K0.00%00.0%Unchanged
Wells Fargo & Company35$210.00%00.0%Unchanged
GWM Advisors LLC4,300$30.00%+4,300New
Simplex Trading, LLC106$00.00%−100−48.5%Reduced
Armistice Capital, LLC0$00.00%−2,797,048−100.0%Sold out
Parkman Healthcare Partners LLC0$00.00%−288,852−100.0%Sold out
Apollon Wealth Management, LLC0$00.00%−48,790−100.0%Sold out
PVG Asset Management Corp0$00.00%−47,860−100.0%Sold out
Virtu Financial LLC0$00.00%−46,168−100.0%Sold out
Envestnet Asset Management Inc0$00.00%−29,839−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−30,394−100.0%Sold out
Rhumbline Advisers0$00.00%−17,092−100.0%Sold out
Opaleye Management Inc.0$00.00%−16,667−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−14,200−100.0%Sold out
Millennium Management LLC0$00.00%−13,403−100.0%Sold out
ACT Capital Management, LLC––––Not filed